Style | Citing Format |
---|---|
MLA | Amidfar M, et al.. "Role of Bdnf Signaling in the Neuroprotective and Memory-Enhancing Effects of Flavonoids in Alzheimer’S Disease." CNS and Neurological Disorders - Drug Targets, vol. 23, no. 8, 2024, pp. 984-995. |
APA | Amidfar M, Garcez ML, Askari G, Bagherniya M, Khorvash F, Golpourhamedani S, De Oliveira J (2024). Role of Bdnf Signaling in the Neuroprotective and Memory-Enhancing Effects of Flavonoids in Alzheimer’S Disease. CNS and Neurological Disorders - Drug Targets, 23(8), 984-995. |
Chicago | Amidfar M, Garcez ML, Askari G, Bagherniya M, Khorvash F, Golpourhamedani S, De Oliveira J. "Role of Bdnf Signaling in the Neuroprotective and Memory-Enhancing Effects of Flavonoids in Alzheimer’S Disease." CNS and Neurological Disorders - Drug Targets 23, no. 8 (2024): 984-995. |
Harvard | Amidfar M et al. (2024) 'Role of Bdnf Signaling in the Neuroprotective and Memory-Enhancing Effects of Flavonoids in Alzheimer’S Disease', CNS and Neurological Disorders - Drug Targets, 23(8), pp. 984-995. |
Vancouver | Amidfar M, Garcez ML, Askari G, Bagherniya M, Khorvash F, Golpourhamedani S, et al.. Role of Bdnf Signaling in the Neuroprotective and Memory-Enhancing Effects of Flavonoids in Alzheimer’S Disease. CNS and Neurological Disorders - Drug Targets. 2024;23(8):984-995. |
BibTex | @article{ author = {Amidfar M and Garcez ML and Askari G and Bagherniya M and Khorvash F and Golpourhamedani S and De Oliveira J}, title = {Role of Bdnf Signaling in the Neuroprotective and Memory-Enhancing Effects of Flavonoids in Alzheimer’S Disease}, journal = {CNS and Neurological Disorders - Drug Targets}, volume = {23}, number = {8}, pages = {984-995}, year = {2024} } |
RIS | TY - JOUR AU - Amidfar M AU - Garcez ML AU - Askari G AU - Bagherniya M AU - Khorvash F AU - Golpourhamedani S AU - De Oliveira J TI - Role of Bdnf Signaling in the Neuroprotective and Memory-Enhancing Effects of Flavonoids in Alzheimer’S Disease JO - CNS and Neurological Disorders - Drug Targets VL - 23 IS - 8 SP - 984 EP - 995 PY - 2024 ER - |